| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | -1.58% | Morgan Stanley | $58 → $59 | Maintains | Equal-Weight |
| 10/30/2023 | -1.58% | BMO Capital | $58 → $59 | Maintains | Market Perform |
| 10/25/2023 | -3.25% | Morgan Stanley | $61 → $58 | Maintains | Equal-Weight |
| 10/24/2023 | 3.42% | Mizuho | $69 → $62 | Maintains | Buy |
| 10/10/2023 | -4.92% | Barclays | $60 → $57 | Maintains | Equal-Weight |
| 10/06/2023 | 10.09% | B of A Securities | $58 → $66 | Upgrades | Neutral → Buy |
| 10/05/2023 | 3.42% | Keybanc | $71 → $62 | Maintains | Overweight |
| 09/21/2023 | 1.75% | Morgan Stanley | $59 → $61 | Maintains | Equal-Weight |
| 09/20/2023 | 3.42% | BMO Capital | $66 → $62 | Maintains | Market Perform |
| 09/15/2023 | 3.42% | Evercore ISI Group | $66 → $62 | Maintains | Outperform |
| 09/06/2023 | 11.76% | RBC Capital | $76 → $67 | Maintains | Sector Perform |
| 08/24/2023 | 0.08% | Barclays | → $60 | Initiates Coverage On | → Equal-Weight |
| 08/23/2023 | -1.58% | Morgan Stanley | $64 → $59 | Maintains | Equal-Weight |
| 08/22/2023 | 0.08% | B of A Securities | $72 → $60 | Downgrades | Buy → Neutral |
| 07/21/2023 | 6.76% | Morgan Stanley | $64 → $64 | Reiterates | Equal-Weight → Equal-Weight |
| 07/19/2023 | 18.43% | Keybanc | $75 → $71 | Maintains | Overweight |
| 06/23/2023 | 6.76% | Morgan Stanley | $65 → $64 | Maintains | Equal-Weight |
| 06/22/2023 | 6.76% | BMO Capital | $69 → $64 | Downgrades | Outperform → Market Perform |
| 06/21/2023 | — | BMO Capital | Downgrades | Outperform → Market Perform | |
| 06/08/2023 | 25.1% | Goldman Sachs | → $75 | Initiates Coverage On | → Buy |
| 06/06/2023 | 16.76% | B of A Securities | $74 → $70 | Maintains | Buy |
| 06/05/2023 | 15.1% | BMO Capital | $75 → $69 | Maintains | Outperform |
| 06/02/2023 | 13.43% | JP Morgan | $79 → $68 | Downgrades | Overweight → Neutral |
| 06/02/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 05/30/2023 | 15.1% | Mizuho | $72 → $69 | Maintains | Buy |
| 05/22/2023 | 8.42% | Morgan Stanley | $67 → $65 | Maintains | Equal-Weight |
| 05/19/2023 | 18.43% | UBS | $72 → $71 | Maintains | Neutral |
| 04/20/2023 | 11.76% | Morgan Stanley | $62 → $67 | Maintains | Equal-Weight |
| 04/19/2023 | 31.78% | JP Morgan | $73 → $79 | Maintains | Overweight |
| 04/05/2023 | 21.77% | BMO Capital | $74 → $73 | Maintains | Outperform |
| 03/21/2023 | 3.42% | Morgan Stanley | $66 → $62 | Maintains | Equal-Weight |
| 03/17/2023 | 20.1% | Mizuho | $75 → $72 | Maintains | Buy |
| 02/22/2023 | 10.09% | Morgan Stanley | $68 → $66 | Maintains | Equal-Weight |
| 01/27/2023 | 21.77% | Wells Fargo | $76 → $73 | Maintains | Equal-Weight |
| 01/23/2023 | 13.43% | Morgan Stanley | $67 → $68 | Maintains | Equal-Weight |
| 01/17/2023 | 25.1% | Keybanc | $73 → $75 | Maintains | Overweight |
| 12/15/2022 | 11.76% | Morgan Stanley | $63 → $67 | Maintains | Equal-Weight |
| 11/21/2022 | 13.43% | Credit Suisse | → $68 | Downgrades | Outperform → Neutral |
| 11/11/2022 | 5.09% | Morgan Stanley | $59 → $63 | Maintains | Equal-Weight |
| 10/21/2022 | -1.58% | Morgan Stanley | $73 → $59 | Maintains | Equal-Weight |
| 10/20/2022 | 15.1% | Wolfe Research | → $69 | Upgrades | Peer Perform → Outperform |
| 10/20/2022 | 13.43% | Keybanc | $78 → $68 | Maintains | Overweight |
| 10/19/2022 | 15.1% | Wells Fargo | $79 → $69 | Maintains | Equal-Weight |
| 10/19/2022 | 8.42% | Mizuho | $72 → $65 | Maintains | Buy |
| 10/19/2022 | 6.76% | Credit Suisse | $72 → $64 | Maintains | Outperform |
| 10/18/2022 | 20.1% | JP Morgan | $86 → $72 | Maintains | Overweight |
| 10/05/2022 | 18.43% | BMO Capital | $80 → $71 | Maintains | Outperform |
| 08/23/2022 | 23.44% | Morgan Stanley | $69 → $74 | Maintains | Equal-Weight |
| 07/21/2022 | 15.1% | Morgan Stanley | $64 → $69 | Maintains | Equal-Weight |
| 07/19/2022 | 30.11% | Keybanc | $79 → $78 | Maintains | Overweight |
| 07/18/2022 | 30.11% | Barclays | $82 → $78 | Maintains | Overweight |
| 06/30/2022 | 18.43% | UBS | $74 → $71 | Maintains | Neutral |
| 05/23/2022 | 20.1% | Morgan Stanley | $75 → $72 | Maintains | Equal-Weight |
| 04/29/2022 | 31.78% | Wells Fargo | $73 → $79 | Maintains | Equal-Weight |
| 04/26/2022 | 33.44% | Credit Suisse | → $80 | Initiates Coverage On | → Outperform |
| 04/20/2022 | 25.1% | Morgan Stanley | $69 → $75 | Maintains | Equal-Weight |
| 04/20/2022 | 31.78% | Keybanc | $78 → $79 | Maintains | Overweight |
| 04/07/2022 | 30.11% | Keybanc | $76 → $78 | Maintains | Overweight |
| 01/25/2022 | 25.1% | Evercore ISI Group | $70 → $75 | Upgrades | In-Line → Outperform |
| 01/13/2022 | 26.77% | Keybanc | $75 → $76 | Maintains | Overweight |
| 01/10/2022 | 20.1% | Mizuho | $64 → $72 | Upgrades | Neutral → Buy |
| 11/22/2021 | 16.76% | BMO Capital | $68 → $70 | Upgrades | Market Perform → Outperform |
| 10/29/2021 | 20.1% | B of A Securities | $67 → $72 | Upgrades | Neutral → Buy |
| 10/19/2021 | 25.1% | Keybanc | $74 → $75 | Maintains | Overweight |
| 10/19/2021 | 8.42% | Morgan Stanley | → $65 | Upgrades | Underweight → Equal-Weight |
| 10/13/2021 | 26.77% | Goldman Sachs | $73 → $76 | Upgrades | Neutral → Buy |
| 10/01/2021 | 26.77% | Barclays | $75 → $76 | Upgrades | Equal-Weight → Overweight |
| 04/21/2021 | 23.44% | Keybanc | $71 → $74 | Maintains | Overweight |
| 04/20/2021 | 8.42% | Morgan Stanley | $60 → $65 | Maintains | Underweight |
| 03/19/2021 | 0.08% | Morgan Stanley | $59 → $60 | Maintains | Underweight |
| 02/18/2021 | -1.58% | Morgan Stanley | $60 → $59 | Maintains | Underweight |
| 01/20/2021 | 0.08% | Morgan Stanley | $62 → $60 | Maintains | Underweight |
| 01/12/2021 | 18.43% | KeyBanc | $75 → $71 | Maintains | Overweight |
| 12/15/2020 | 3.42% | Morgan Stanley | $67 → $62 | Maintains | Underweight |
| 11/17/2020 | 11.76% | Morgan Stanley | $65 → $67 | Maintains | Underweight |
| 10/27/2020 | 20.1% | Mizuho | $68 → $72 | Maintains | Neutral |
| 10/20/2020 | 8.42% | Morgan Stanley | $60 → $65 | Maintains | Underweight |
| 10/19/2020 | 25.1% | Keybanc | $74 → $75 | Maintains | Overweight |
| 08/25/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 07/21/2020 | 23.44% | Keybanc | $66 → $74 | Maintains | Overweight |
| 07/17/2020 | -1.58% | Morgan Stanley | $56 → $59 | Maintains | Underweight |
| 06/17/2020 | -6.59% | Morgan Stanley | $55 → $56 | Maintains | Underweight |
| 05/13/2020 | -8.26% | Morgan Stanley | $61 → $55 | Downgrades | Equal-Weight → Underweight |
| 04/24/2020 | — | Wells Fargo | Downgrades | Overweight → Equal-Weight | |
| 04/15/2020 | 5.09% | Mizuho | $53 → $63 | Maintains | Neutral |
| 04/15/2020 | 1.75% | Morgan Stanley | $64 → $61 | Maintains | Equal-Weight |
| 03/27/2020 | 6.76% | JP Morgan | $69 → $64 | Maintains | Overweight |
| 03/26/2020 | -9.92% | Barclays | $70 → $54 | Maintains | Equal-Weight |
| 03/16/2020 | 8.42% | UBS | $75 → $65 | Maintains | Neutral |
| 03/12/2020 | 6.76% | Morgan Stanley | $70 → $64 | Maintains | Equal-Weight |
| 02/20/2020 | 13.43% | BMO Capital | → $68 | Initiates Coverage On | → Market Perform |
| 01/31/2020 | 28.44% | Wells Fargo | $70 → $77 | Maintains | Overweight |
| 01/31/2020 | 16.76% | B of A Securities | → $70 | Upgrades | Underperform → Neutral |
| 01/30/2020 | 6.76% | CFRA | $62 → $64 | Maintains | Sell |
| 01/17/2020 | 10.09% | Keybanc | $73 → $66 | Maintains | Overweight |
| 12/16/2019 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 10/21/2019 | 21.77% | Keybanc | $67 → $73 | Maintains | Overweight |
| 10/10/2019 | 6.76% | Mizuho | $50 → $64 | Maintains | Neutral |
| 09/30/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 09/06/2019 | 5.09% | Morgan Stanley | $60 → $63 | Maintains | Equal-Weight |
| 09/06/2019 | 10.09% | UBS | $63 → $66 | Maintains | Neutral |
| 08/16/2019 | 0.08% | Morgan Stanley | $61 → $60 | Maintains | Equal-Weight |
| 08/13/2019 | 6.76% | Barclays | → $64 | Downgrades | Overweight → Equal-Weight |
| 06/14/2019 | 0.08% | Morgan Stanley | $57 → $60 | Maintains | Equal-Weight |
What is the target price for Xcel Energy (XEL)?
The latest price target for Xcel Energy (NASDAQ: XEL) was reported by Morgan Stanley on November 21, 2023. The analyst firm set a price target for $59.00 expecting XEL to fall to within 12 months (a possible -1.58% downside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xcel Energy (XEL)?
The latest analyst rating for Xcel Energy (NASDAQ: XEL) was provided by Morgan Stanley, and Xcel Energy maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Xcel Energy (XEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xcel Energy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xcel Energy was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Xcel Energy (XEL) correct?
While ratings are subjective and will change, the latest Xcel Energy (XEL) rating was a maintained with a price target of $58.00 to $59.00. The current price Xcel Energy (XEL) is trading at is $59.95, which is out of the analyst's predicted range.